首页> Oncotarget> Estrogen receptor alpha drives proliferation in PTEN-deficient prostate carcinoma by stimulating survival signaling, MYC expression and altering glucose sensitivity.

Estrogen receptor alpha drives proliferation in PTEN-deficient prostate carcinoma by stimulating survival signaling, MYC expression and altering glucose sensitivity.

导出 OA

翻译打印收藏纠错

第一作者： Itsuhiro,Takizawa

第一单位： Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia.

作者： Itsuhiro,Takizawa ^[1] ; Mitchell G,Lawrence ^[1] ; Preetika,Balanathan ^[1] ; Richard,Rebello ^[1] ; Helen B,Pearson ^[2] ; Elika,Garg ^[3] ; John,Pedersen ^[4] ; Normand,Pouliot ^[2] ; Robert,Nadon ^[5] ; Matthew J,Watt ^[6] ; Renea A,Taylor ^[6] ; Patrick,Humbert ^[7] ; Ivan,Topisirovic ^[8] ; Ola,Larsson ^[9] ; Gail P,Risbridger ^[1] ; Luc,Furic ^[1]

作者单位： Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia. ^[1] Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.;Sir Peter MacCallum Department of Oncology, Melbourne University, Victoria, Australia. ^[2] Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital and Departments of Oncology, Experimental Medicine and Biochemistry, McGill University, Montréal, Canada.;Department of Human Genetics, McGill University, Montréal, Canada. ^[3] TissuPath Pathology, Melbourne, Victoria, Australia. ^[4] Department of Human Genetics, McGill University, Montréal, Canada. ^[5] Department of Physiology, Monash University, Clayton, Victoria, Australia. ^[6] Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.;Sir Peter MacCallum Department of Oncology, Melbourne University, Victoria, Australia.;Department of Pathology and Department of Biochemistry and Molecular Biology, the University of Melbourne, Parkville, Australia. ^[7] Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital and Departments of Oncology, Experimental Medicine and Biochemistry, McGill University, Montréal, Canada. ^[8] Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. ^[9]